Replies to post #205195 on Biotech Values

[DewDiligence]

TGTX—If I were to guess I would say the company doesn't want to give people too much time to digest the data before the CC which generally seems like a bad thing. I haven't done an analysis but wondering if others can think of when it was actually a positive situation.

DNDN in 2009 was one such instance (#msg-36997119).